In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells

International Journal of Artificial Organs

Volumn 23, Issue 7, 2000, Pages 429-435

  Prakash, S ^a   Chang, T M S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Artificial cell; E. coli DH5 cells; Genetically engineered cells; Gout; Microcapsules; Uric acid

Indexed keywords

ARTIFICIAL CELLS; CHEMOTHERAPY; CYTOLOGY; DRUG INTERACTIONS; ENCAPSULATION; GENETIC ENGINEERING; ORGANIC ACIDS;

ARTIFICIAL CELL; E COLI DH5 CELL; E. COLI; GENETICALLY ENGINEERED CELL; GOUT; IN-VITRO; MICROCAPSULES; SIDE EFFECT; URIC ACIDS; VITRO AND IN VIVO;

ESCHERICHIA COLI;

URIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC ENGINEERING; GOUT; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; MALE; MICROCAPSULE; MICROENCAPSULATION; NONHUMAN; RAT; URIC ACID BLOOD LEVEL;

EID: 0033898773     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300704     Document Type: Article

References (29)

1. Renal disease from excess uric acid
2. Gout and hyperuricemia
3. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study
4. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease
5. Gout, uric acid and renal disease
6. Diagnosis and management of gout
7. Colchicine: 1998 update
8. Drugs to lower uric acid levels. How to avoid misuse in gouty arthritis
9. Pharmocology
10. Hyperuricemic nephropathies
11. Hyperuricemia and renal insufficiency associated with malignant disease: Urate oxidase as an efficient therapy?
12. Hyperuricemia and urate nephropathy in urate oxidasedeficient mice
13. Struggling to deliver ESRD therapy in developing nations
14. Semipermeable microcapsules
15. Artificial Cells'
16. Artificial cells and bioencapsulation in bioartificial organs
17. Microencapsulated genetically engineered lvie E. coli DHS cells administered orally to maintain normal plasma urea level in uremic rats
18. Therapeutic uses of microencapsulated genetically engineered cells
19. Preparation and in vitro analysis of geneticaly Engineered E. coli DH5 cells, microencapsulated in artificial cells for urea and ammonia removal:
20. Artificial cells for bioencapsulation of cells and genetically engineered E. coli: for cell therapy, gene therapy and removal of urea and ammonia
21. Encapsulation for somatic gene therapy
22. Advantages of microencapsulation as an immunoprotection method in the transplantation of pancreatic islets
23. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts
24. Microbial ureases: Significance, regulation, and molecular characterization
25. Regulation of gene expression and cellular localization of cloned K. aerogens urease
26. Immobilization of E. coli expressing the lux gene of Xenorhabdus luminescenc